Bangladesh's Beximco Pharma has claimed a world first after launching a generic version of remdesivir for the treatment of COVID-19. The launch in the firm’s domestic market comes after the country’s Directorate General of Drug Administration today granted an emergency use authorization for Beximco’s remdesivir IV injection, under the brand name Bemsivir.
Beximco Launches First Remdesivir Generic
World’s First Generic Version Of COVID-19 Treatment Introduced In Bangladesh
Bangladesh's Beximco has claimed a world first with the launch of a generic version of remdesivir in its domestic market. Local authorities have granted an emergency use authorization for the COVID-19 treatment amid the coronavirus pandemic.
